Barre verticale Université de Lausanne - Unisciences
 
 
Séparateur Annuaire Séparateur Actualités Séparateur Aide Séparateur Login
Langues:  fr | en
Transparent
RECHERCHE
Transparent
Transparent
Transparent
Photo ambiance
UNIL > Unisciences >
MyUNIL
Transparent
AFFICHER LES DONNEES
Transparent
de à
Données actuelles
Transparent

Centre universitaire romand de médecine légale

Coordonnées Equipe Recherches Publications  
Equipe principale | Laboratoire suisse d'analyse du dopage (LAD) | Unité d'imagerie et d'anthropologie forensiques (UIAF) | Unité de droit médical, éthique et médecine humanitaire (DMMH) | Unité de génétique forensique (UGF) | Unité de médecine des violences (UMV) | Unité de médecine et psychologie du trafic (UMPT) | Unité de médecine forensique (UMF) | Unité de psychiatrie légale (PL) | Unité de toxicologie et chimie forensique (UTCF) |

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


271 publications

2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | ...
Worldwide distribution of blood values in elite track and field athletes: biomarkers of altered erythropoiesis.
Robinson N., Saugy J., Schütz F., Faiss R., Baume N., Giraud S., Saugy M., 2018/10/22. Drug testing and analysis. Peer-reviewed.
 
Quel est l'apport de la chromatographie en phase supercritique pour l'analyse antidopage ?
Guillarme D., Novakova L., Desfontaine V., Nicoli R., Saugy M., Kuuranne T., Veuthey J.-L., 2018/06. pp. S35-S36 dans Toxicologie Analytique et Clinique, Elsevier BV.
 
Stratégies d'analyse de substances et méthodes interdites dans la pratique du sport : défis actuels et tendances futures
Nicoli R., Ponzetto F., Saugy M., Kuuranne T., 2018/06. pp. S34 dans Toxicologie Analytique et Clinique, Elsevier BV.
 
Erythropoietin as a performance-enhancing drug: Its mechanistic basis, detection, and potential adverse effects.
Salamin O., Kuuranne T., Saugy M., Leuenberger N., 2018/03/15. Molecular and cellular endocrinology, 464 pp. 75-87. Peer-reviewed.
 
Systematic evaluation of matrix effects in supercritical fluid chromatography versus liquid chromatography coupled to mass spectrometry for biological samples.
Desfontaine V., Capetti F., Nicoli R., Kuuranne T., Veuthey J.L., Guillarme D., 2018/03/15. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1079 pp. 51-61. Peer-reviewed.
 
Analytical challenges in sports drug testing.
Thevis M., Krug O., Geyer H., Walpurgis K., Baume N., Thomas A., 2018/03. Analytical and bioanalytical chemistry, 410 (9) pp. 2275-2281. Peer-reviewed.
 
Transcriptomic biomarkers of altered erythropoiesis to detect autologous blood transfusion.
Salamin O., Mignot J., Kuuranne T., Saugy M., Leuenberger N., 2018/03. Drug testing and analysis, 10 (3) pp. 604-608. Peer-reviewed.
 
Annual banned-substance review: Analytical approaches in human sports drug testing.
Thevis M., Kuuranne T., Geyer H., 2018/01. Drug testing and analysis, 10 (1) pp. 9-27. Peer-reviewed.
 
UHPLC-HRMS Analysis for Steroid Profiling in Serum (Steroidomics).
Ponzetto F., Boccard J., Nicoli R., Kuuranne T., Saugy M., Rudaz S., 2018. pp. 261-278 dans Methods in molecular biology, Springer.
 
Loop-mediated isothermal amplification (LAMP) as an alternative to PCR: A rapid on-site detection of gene doping.
Salamin O., Kuuranne T., Saugy M., Leuenberger N., 2017/11. Drug testing and analysis, 9 (11-12) pp. 1731-1737. Peer-reviewed.
 
Individual hemoglobin mass response to normobaric and hypobaric "live high-train low": A one-year crossover study.
Hauser A., Troesch S., Saugy J.J., Schmitt L., Cejuela-Anta R., Faiss R., Steiner T., Robinson N., Millet G.P., Wehrlin J.P., 2017/08/01. Journal of applied physiology, 123 (2) pp. 387-393. Peer-reviewed.
 
Hepcidin as a potential biomarker for blood doping.
Leuenberger N., Bulla E., Salamin O., Nicoli R., Robinson N., Baume N., Saugy M., 2017/07. Drug testing and analysis, 9 (7) pp. 1093-1097. Peer-reviewed.
 
RNA stabilized blood tubes to measure haemoglobin concentration.
Leuenberger N., Schobinger C., Salamin O., Saugy M., Kuuranne T., 2017/06. Drug testing and analysis, 9 (6) pp. 942-943. Peer-reviewed.
 
High-resolution mass spectrometry as an alternative detection method to tandem mass spectrometry for the analysis of endogenous steroids in serum.
Ponzetto F., Boccard J., Baume N., Kuuranne T., Rudaz S., Saugy M., Nicoli R., 2017/05/01. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1052 pp. 34-42. Peer-reviewed.
 
Annual banned-substance review: analytical approaches in human sports drug testing.
Thevis M., Kuuranne T., Geyer H., Schänzer W., 2017/01. Drug testing and analysis, 9 (1) pp. 6-29. Peer-reviewed.
 
Integration of the Forensic Dimension into Anti-Doping Strategies
Marclay F., Saugy M., 2017. Medicine and sport science, 62 pp. 129-138. Peer-reviewed.
 
Validation of a Blood Stability Score as an easy-to-use blood sample quality index.
Robinson N., Kirchbichler A., Banuls O., Mader M., Aikin R., Sottas P.E., D'Onofrio G., 2016/12. International journal of laboratory hematology, 38 (6) pp. 685-693. Peer-reviewed.
 
Impact of blood transfusion on gene expression in human reticulocytes.
Salamin O., Barras L., Robinson N., Baume N., Tissot J.D., Pitsiladis Y., Saugy M., Leuenberger N., 2016/10. American journal of hematology, 91 (10) pp. E460-1. Peer-reviewed.
 
Autologous Blood Transfusion in Sports: Emerging Biomarkers.
Salamin O., De Angelis S., Tissot J.D., Saugy M., Leuenberger N., 2016/07. Transfusion medicine reviews, 30 (3) pp. 109-115. Peer-reviewed.
 
Evaluation of longitudinal steroid profiles from male football players in UEFA competitions between 2008 and 2013.
Baume N., Geyer H., Vouillamoz M., Grisdale R., Earl M., Aguilera R., Cowan D.A., Ericsson M., Gmeiner G., Kwiatkowska D. et al., 2016/07. Drug testing and analysis, 8 (7) pp. 603-612. Peer-reviewed.
Les défis du passeport biologique: du prélèvement à l’interprétation
Robinson N., Baume N., 2016/06/30. Swiss Sports & Exercise Medicine, 64 (3) pp. 23-28. Peer-reviewed.
Retesting the anti-doping samples: Best tool for deterrence?
Kuuranne T., Saugy M., 2016/06/01. Swiss Sports & Exercise Medicine, 64 (3) pp. 19-22. Peer-reviewed.
 
Risk of false positive results to SARM S-4 in case of therapeutic use of antineoplastic/antiandrogen drug containing flutamide: a case study.
Perrenoud L., Schweizer Grundisch C., Baume N., Saugy M., Nicoli R., 2016/04. Drug testing and analysis, 8 (11-12) pp. 1109-1113. Peer-reviewed.
 
Longitudinal Monitoring of Endogenous Blood Steroids as a Tool to Detect Testosterone Abuse in Sport
Ponzetto Federico, Boccardb Julien, Baume Norbert, Rudazb Serge, Saugya Martial, Nicolia Raul, 2016/03/30. CHIMIA International Journal for Chemistry, 70 (3) pp. 208-208. Peer-reviewed.
 
Pre-analytical and analytical aspects of EDTA-plasma iron measurement.
Leuenberger N., Baume N., Robinson N., Saugy M., 2016/03. Drug testing and analysis, 8 (10) pp. 1077-1079. Peer-reviewed.
 
Influence of transport and time on blood variables commonly measured for the athlete biological passport.
Robinson N., Giraud S., Schumacher Y.O., Saugy M., 2016/02. Drug testing and analysis, 8 (2) pp. 199-207. Peer-reviewed.
 
Analytical Strategies for Doping Control Purposes: Needs, Challenges, and Perspectives.
Nicoli R., Guillarme D., Leuenberger N., Baume N., Robinson N., Saugy M., Veuthey J.L., 2016. Analytical Chemistry, 88 (1) pp. 508-523. Peer-reviewed.
Circulating microRNA-122 as Potential Biomarker for Detection of Testosterone Abuse.
Salamin O., Jaggi L., Baume N., Robinson N., Saugy M., Leuenberger N., 2016. Plos One, 11 (5) pp. e0155248. Peer-reviewed.
 
Evaluation of steroidomics by liquid chromatography hyphenated to mass spectrometry as a powerful analytical strategy for measuring human steroid perturbations.
Jeanneret F., Tonoli D., Rossier M.F., Saugy M., Boccard J., Rudaz S., 2016. Journal of Chromatography. A, 1430 pp. 97-112. Peer-reviewed.
 
Fast and sensitive supercritical fluid chromatography - tandem mass spectrometry multi-class screening method for the determination of doping agents in urine.
Nováková L., Desfontaine V., Ponzetto F., Nicoli R., Saugy M., Veuthey J.L., Guillarme D., 2016. Analytica Chimica Acta, 915 pp. 102-110. Peer-reviewed.
 
Hepcidin as a new biomarker for detecting autologous blood transfusion.
Leuenberger N., Barras L., Nicoli R., Robinson N., Baume N., Lion N., Barelli S., Tissot J.D., Saugy M., 2016. American Journal of Hematology, 91 (5) pp. 467-472. Peer-reviewed.
 
Liquid chromatography and supercritical fluid chromatography as alternative techniques to gas chromatography for the rapid screening of anabolic agents in urine.
Desfontaine V., Nováková L., Ponzetto F., Nicoli R., Saugy M., Veuthey J.L., Guillarme D., 2016. Journal of Chromatography. A, 1451 pp. 145-155. Peer-reviewed.
 
Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports.
Ponzetto F., Mehl F., Boccard J., Baume N., Rudaz S., Saugy M., Nicoli R., 2016/01. Analytical and bioanalytical chemistry, 408 (3) pp. 705-719. Peer-reviewed.
 
Methods for Doping Detection.
Ponzetto F., Giraud S., Leuenberger N., Boccard J., Nicoli R., Baume N., Rudaz S., Saugy M., 2016. pp. 153-167 dans Sports Endocrinology, Karger.
 
Response
Wehrlin J.P., Hauser A., Schmitt L., Troesch S., Saugy J. J., Cejula-Anta R., Faiss R., Robinson N., Millet G.P., 2016. Medicine and Science In Sports and Exercise, 48 (7) pp. 1426-1427. Peer-reviewed.
Same Performance Changes after Live High-Train Low in Normobaric vs. Hypobaric Hypoxia.
Saugy J.J., Schmitt L., Hauser A., Constantin G., Cejuela R., Faiss R., Wehrlin J.P., Rosset J., Robinson N., Millet G.P., 2016. Frontiers In Physiology, 7 (138) p. 138. Peer-reviewed.
 
Similar Hemoglobin Mass Response in Hypobaric and Normobaric Hypoxia in Athletes
Hauser A., Schmitt L., Troesch S., Saugy J.J., Cejuela-Anta R., Faiss R., Robinson N., Wehrlin J.P., Millet G.P., 2016. Medicine and Science In Sports and Exercise, 48 (4) pp. 734-741. Peer-reviewed.
 
Urinary di-(2-ethylhexyl) phthalate metabolites for detecting transfusion of autologous blood stored in plasticizer-free bags.
Leuenberger N., Barras L., Nicoli R., Robinson N., Baume N., Lion N., Barelli S., Tissot J.D., Saugy M., 2016. Transfusion, 56 (3) pp. 571-578. Peer-reviewed.
Antidoping programme and biological monitoring before and during the 2014 FIFA World Cup Brazil.
Baume N., Jan N., Emery C., Mandanis B., Schweizer C., Giraud S., Leuenberger N., Marclay F., Nicoli R., Perrenoud L. et al., 2015. British Journal of Sports Medicine, 49 (9) pp. 614-622. Peer-reviewed.
 
Blood monitoring of perfluorocarbon compounds (F-tert-butylcyclohexane, perfluoromethyldecalin and perfluorodecalin) by headspace-gas chromatography-tandem mass spectrometry.
Giuliani N., Saugy M., Augsburger M., Varlet V., 2015. Talanta, 144 pp. 196-203. Peer-reviewed.
 
Circulating microRNAs: The Future of Biomarkers in Anti-doping Field.
Leuenberger N., Saugy M., 2015. Advances In Experimental Medicine and Biology, 888 pp. 401-408. Peer-reviewed.
 
Is urine thc-cooh a proper marker for problematic cannabis use?
Belanger RE, Marclay F., Saugy M., Suris JC, 2015. pp. S28-S28 dans SAHM 2015 Annual Meeting, Journal of Adolescent Health. Peer-reviewed.
 
The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
Holt R.I., Böhning W., Guha N., Bartlett C., Cowan D.A., Giraud S., Bassett E.E., Sönksen P.H., Böhning D., 2015. Drug Testing and Analysis, 7 (9) pp. 745-755. Peer-reviewed.
 
Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. I: Investigation of mobile phase and MS conditions.
Nováková L., Grand-Guillaume Perrenoud A., Nicoli R., Saugy M., Veuthey J.L., Guillarme D., 2015. Analytica Chimica Acta, 853 pp. 637-646. Peer-reviewed.
 
Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: Analysis of biological samples.
Nováková L., Rentsch M., Grand-Guillaume Perrenoud A., Nicoli R., Saugy M., Veuthey J.L., Guillarme D., 2015. Analytica Chimica Acta, 853 pp. 647-659. Peer-reviewed.
 
Role of Anti-Doping Laboratories in the Fight against Doping
Giraud S., Joye C., Saugy M., Viret M., 2014/10/01. Causa Sport, 4 pp. 331-344. Peer-reviewed.
 
A fast automated screening method for the detection of blood transfusion in sports.
Leuenberger N., Ansermet C., Pottgiesser T., Baume N., Robinson N., Saugy M., Schumacher Y.O., 2014. Drug Testing and Analysis, 6 (11-12) pp. 1141-1143. Peer-reviewed.
 
A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
Harcourt P.R., Marclay F., Clothier B., 2014. British Journal of Sports Medicine, 48 (10) pp. 810-813.
 
Challenges and threats to implementing the fight against doping in sport
Dvorak J., Saugy M., Pitsiladis Y.P., 2014. British Journal of Sports Medicine, 48 (10) pp. 807-809. Peer-reviewed.
Comparison of "Live High-Train Low" in Normobaric versus Hypobaric Hypoxia.
Saugy J.J., Schmitt L., Cejuela R., Faiss R., Hauser A., Wehrlin J.P., Rudaz B., Delessert A., Robinson N., Millet G.P., 2014. PLoS One, 9 (12) pp. e114418. Peer-reviewed.
Confounding factors and genetic polymorphism in the evaluation of individual steroid profiling
Kuuranne T., Saugy M., Baume N., 2014. British Journal of Sports Medicine, 48 (10) pp. 848-855.
 
Degradation of methyltestosterone in urine samples.
Schweizer Grundisch C., Baume N., Saugy M., 2014. Drug Testing and Analysis, 6 (11-12) pp. 1170-1173. Peer-reviewed.
 
Determination of 13C/12C ratios of endogenous urinary 5-amino-imidazole-4-carboxamide 1-D-ribofuranoside (AICAR)
Piper T., Thomas A., Baume N., Sobolevsky T., Saugy M., Rodchenkov G., Schänzer W., Thevis M., 2014. Rapid Communications in Mass Spectrometry : Rcm, 28 (11) pp. 1194-1202. Peer-reviewed.
 
Dopage : aspects médico-techniques
Baume N., Jan N., Leuenberger N., Mangin P., Marclay F., Robinson N., Saugy M., 2014. pp. 809-821 dans Droit de la santé et médecine légale chap. 81, Chêne-Bourg : Ed. Médecine et Hygiène.
 
Drawing the map to implement the 2015 World Anti-Doping Code
Dvorak J., Budgett R., Saugy M., Vernec A., 2014. British Journal of Sports Medicine, 48 (10) p. 800.
 
Droit de la santé et médecine légale
La Harpe R., Ummel M., Dumoulin JF, Rotman S., Baume N., Egger C., Elger B., Favrat B., Fracasso T., Gehrig C. et al., 2014. 810, Chêne-Bourg : Médecine & Hygiène.
 
Les principaux changements - Deuxième partie: le point de vue du laboratoire
Saugy M., 2014. dans Arbitrage des litiges dans le monde sportif moderne - 5ème Conférence TAS & FSA / SAV.
 
Monitoring of biological markers indicative of doping: the athlete biological passport
Saugy M., Lundby C., Robinson N., 2014. British Journal of Sports Medicine, 48 (10) pp. 827-832.
 
Serum androgen levels in elite female athletes.
Bermon S., Garnier P.Y., Hirschberg A.L., Robinson N., Giraud S., Nicoli R., Baume N., Saugy M., Fénichel P., Bruce S.J. et al., 2014. Journal of Clinical Endocrinology and Metabolism, 99 (11) pp. 4328-4335. Peer-reviewed.
 
The effect of a period of intense exercise on the marker approach to detect growth hormone doping in sports.
Voss S.C., Robinson N., Alsayrafi M., Bourdon P.C., Schumacher Y.O., Saugy M., Giraud S., 2014. Drug Testing and Analysis, 6 (6) pp. 582-586.
 
The hematology laboratory in blood doping (bd): 2014 update on the athlete biological passport (APB)
d'Onofrio G., Zini G., Robinson N., Schumacher YO, 2014. pp. 31-32 dans XXVII International Symposium on Technological Innovations in Laboratory Hematology,, International journal of laboratory hematology. Peer-reviewed.
The UEFA EURO 2012 anti-doping programme - scientific review
Earl M., Vouillamoz M., Kwiatkowska D., Turek-Lepa E., Pokrywka A., Saugy M., Baume N., Gmeiner G., 2014. Biology of Sport / Institute of Sport, 31 (2) pp. 85-93.
Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015
Dvorak J., Baume N., Botré F., Broséus J., Budgett R., Frey W.O., Geyer H., Harcourt P.R., Ho D., Howman D. et al., 2014. British Journal of Sports Medicine, 48 (10) pp. 801-806.
 
Untargeted profiling of urinary steroid metabolites after testosterone ingestion: opening new perspectives for antidoping testing.
Boccard J., Badoud F., Jan N., Nicoli R., Schweizer C., Pralong F., Veuthey J.L., Baume N., Rudaz S., Saugy M., 2014. Bioanalysis, 6 (19) pp. 2523-2536. Peer-reviewed.
 
Le changement de paradigme du Renseignement Forensique pour la lutte contre le dopage organisé et le trafic de substances interdites
Marclay F., Jan N., Esseiva P., Mangin P., Margot P., Saugy M., 2013/12. Revue internationale de criminologie et de police technique et scientifique, LXVI (4) pp. 451-472.
 
Effect of changes in the deuterium content of drinking water on the hydrogen isotope ratio of urinary steroids in the context of sports drug testing.
Piper T., Degenhardt K., Federherr E., Thomas A., Thevis M., Saugy M., 2013/11. Analytical and Bioanalytical Chemistry, 405 (9) pp. 2911-2921. Peer-reviewed.
Circulating microRNAs as biomarkers for detection of autologous blood transfusion.
Leuenberger N., Schumacher Y.O., Pradervand S., Sander T., Saugy M., Pottgiesser T., 2013. Plos One, 8 (6) pp. e66309. Peer-reviewed.
 
Circulating miRNAs: a new generation of anti-doping biomarkers
Leuenberger N., Robinson N., Saugy M., 2013. Analytical and Bioanalytical Chemistry, 405 (30) pp. 9617-9623. Peer-reviewed.
 
Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing.
Piper T., Emery C., Thomas A., Saugy M., Thevis M., 2013. Analytical and Bioanalytical Chemistry, 405 (16) pp. 5455-5466.
 
Perspectives for Forensic Intelligence in anti-doping: Thinking outside of the box.
Marclay F., Mangin P., Margot P., Saugy M., 2013. Forensic Science International, 229 (1-3) pp. 133-144.
 
Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
Badoud F., Boccard J., Schweizer C., Pralong F., Saugy M., Baume N., 2013. Journal of Steroid Biochemistry and Molecular Biology, 138 pp. 222-235.
 
Quantification of clenbuterol at trace level in human urine by ultra-high pressure liquid chromatography-tandem mass spectrometry.
Nicoli R., Petrou M., Badoud F., Dvorak J., Saugy M., Baume N., 2013. Journal of Chromatography. A, 1292 pp. 142-150.
 
Statistical discrimination of steroid profiles in doping control with support vector machines.
Van Renterghem P., Sottas P.E., Saugy M., Van Eenoo P., 2013. Analytica Chimica Acta, 768 pp. 41-48.
 
The effect of a period of intensive exercise on the isoform test to detect growth hormone doping in sports.
Voss S.C., Giraud S., Alsayrafi M., Bourdon P.C., Schumacher Y.O., Saugy M., Robinson N., 2013. Growth Hormone and Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society, 23 (4) pp. 105-108.
 
To what extent does adding tobacco to cannabis expose young users to nicotine?
Bélanger R.E., Marclay F., Berchtold A., Saugy M., Cornuz J., Suris J.C., 2013. Nicotine and Tobacco Research, 15 (11) pp. 1832-1838. Peer-reviewed.
 
Investigations on carbon isotope ratios and concentrations of urinary formestane.
Piper T., Fusshöller G., Emery C., Schänzer W., Saugy M., 2012/12. Drug Testing and Analysis, 4 (12) pp. 942-950.
 
2011 lAAF World Championships in Daegu: blood tests for all athletes in the framework of the Athlete Biological Passport.
Robinson N., Dollé G., Garnier P.Y., Saugy M., 2012. Bioanalysis, 4 (13) pp. 1633-1643. Peer-reviewed.
 
Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.
Georgakopoulos C., Saugy M., Giraud S., Robinson N., Alsayrafi M., 2012. Bioanalysis, 4 (13) pp. 1549-1563.
 
Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
Schumacher Y.O., Saugy M., Pottgiesser T., Robinson N., 2012. Drug Testing and Analysis, 4 (11) pp. 846-853. Peer-reviewed.
 
Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.
Leuenberger N., Reichel C., Lasne F., 2012. Bioanalysis, 4 (13) pp. 1565-1575. Peer-reviewed.
 
Influences of β-HCG administration on carbon isotope ratios of endogenous urinary steroids.
Piper T., Baume N., Strahm E., Emery C., Saugy M., 2012. Steroids, 77 (6) pp. 644-654.
 
Investigations on hydrogen isotope ratios of endogenous urinary steroids: reference-population-based thresholds and proof-of-concept.
Piper T., Thomas A., Thevis M., Saugy M., 2012. Drug Testing and Analysis, 4 (9) pp. 717-727.
 
The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivation.
Fürstenberger C., Vuorinen A., Da Cunha T., Kratschmar D.V., Saugy M., Schuster D., Odermatt A., 2012. Toxicological Sciences : An Official Journal of the Society of Toxicology, 126 (2) pp. 353-361. Peer-reviewed.
 
Ultra-high Pressure Liquid Chromatography coupled to Mass Spectrometry in Doping Control Analysis
Badoud F., Saugy M., Veuthey JL, 2012. pp. 283-315 dans UHPLC in Life Sciences chap. 10, London : Royal Society of Chemistry.
 
Influence of multiple injections of human chorionic gonadotropin (hCG) on urine and serum endogenous steroids concentrations.
Strahm E., Marques-Vidal P., Pralong F., Dvorak J., Saugy M., Baume N., 2011/12/10. Forensic science international, 213 (1-3) pp. 62-72. Peer-reviewed.
Systemic effects of epidural Methylprednisolone injection on glucose tolerance in diabetic patients.
Zufferey P., Bulliard C., Gremion G., Saugy M., So A., 2011/12. BMC Research Notes, 4 (1) p. 552.
 
Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes.
Thomas A., Solymos E., Schänzer W., Baume N., Saugy M., Dellanna F., Thevis M., 2011/11. Analytica Chimica Acta, 707 (1-2) pp. 107-113.
 
Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.
Pottgiesser T., Sottas P.E., Echteler T., Robinson N., Umhau M., Schumacher Y.O., 2011/08. Transfusion, 51 (8) pp. 1707-1715.
 
Recent developments in the use of isotope ratio mass spectrometry in sports drug testing.
Piper T., Emery C., Saugy M., 2011/08. Analytical and Bioanalytical Chemistry, 401 (2) pp. 433-447. Peer-reviewed.
 
The athlete biological passport.
Sottas P.E., Robinson N., Rabin O., Saugy M., 2011/07. Clinical Chemistry, 57 (7) pp. 969-976. Peer-reviewed.
 
The athlete biological passport: an effective tool in the fight against doping.
Robinson N., Saugy M., Vernec A., Pierre-Edouard S., 2011/06. Clinical Chemistry, 57 (6) pp. 830-832.
 
Prevalence of blood doping in samples collected from elite track and field athletes.
Sottas P.E., Robinson N., Fischetto G., Dollé G., Alonso J.M., Saugy M., 2011/05. Clinical Chemistry, 57 (5) pp. 762-769.
 
A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports.
Van Renterghem P., Van Eenoo P., Sottas P.E., Saugy M., Delbeke F., 2011/02. Clinical Endocrinology, - (-) pp. -.
 
A one-year monitoring of nicotine use in sport: frontier between potential performance enhancement and addiction issues.
Marclay F., Grata E., Perrenoud L., Saugy M., 2011. Forensic Science International, 213 (1-3) pp. 73-84. Peer-reviewed.
 
A steroidomic approach for biomarkers discovery in doping control.
Boccard J., Badoud F., Grata E., Ouertani S., Hanafi M., Mazerolles G., Lantéri P., Veuthey J.L., Saugy M., Rudaz S., 2011. Forensic science international, 213 (1-3) pp. 85-94.
 
Analytical aspects in doping control: challenges and perspectives.
Badoud F., Guillarme D., Boccard J., Grata E., Saugy M., Rudaz S., Veuthey J.L., 2011. Forensic science international, 213 (1-3) pp. 49-61.
 
Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse.
Leuenberger N., Jan N., Pradervand S., Robinson N., Saugy M., 2011. Drug Testing and Analysis, 3 (11-12) pp. 771-776.
 
Dépistage anti-dopage: sciences et techniques analytiques au service du sport
Saugy M., Baume N., Robinson N., 2011. pp. 3-20 dans Le dopage dans le sport : état des lieux et nouvelles perspectives : actes du Colloque scientifique à l'occasion du 15ème anniversaire du CIES, Neuchâtel, 28 janvier 2011, Neuchâtel : Ed. CIES.
 
Fluorescence flow cytometer to determine urine particle reference intervals in doping control samples.
Robinson N., Sottas P.E., Saugy M., 2011. Forensic science international, 213 (1-3) pp. 95-100.
 
Future of the fight against doping: risk assessment, biological profiling and intelligence testing.
Saugy M., Robinson N., Grimm K., Dvorak J., 2011. Forensic Science International, 213 (1-3) pp. 1-2.
 
How to confirm C.E.R.A. doping in athletes' blood?
Leuenberger N., Lamon S., Robinson N., Giraud S., Saugy M., 2011. Forensic science international, 213 (1-3) pp. 101-3.
 
Is cannabis use a significant exposition to nicotine?
Bélanger Richard E., Marclay François, Berchtold André, Akré Christina, Saugy Martial, Suris Joan-Carles, 2011. pp. S71-S72 dans 2011 SAHM Annual Meeting (Society for Adolescent Health and Medicine), Journal of Adolescent Health. Peer-reviewed.
 
Methods for detection and confirmation of Hematide?/peginesatide in anti-doping samples.
Leuenberger N., Saugy J., Mortensen R.B., Schatz P.J., Giraud S., Saugy M., 2011. Forensic science international, 213 (1-3) pp. 15-19.
 
Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry.
Badoud F., Grata E., Boccard J., Guillarme D., Veuthey J.L., Rudaz S., Saugy M., 2011. Analytical and Bioanalytical Chemistry, 400 (2) pp. 503-516.
 
SARM-S4 and metabolites detection in sports drug testing: a case report.
Grata E., Perrenoud L., Saugy M., Baume N., 2011. Forensic science international, 213 (1-3) pp. 104-8.
 
Source inference of exogenous gamma-hydroxybutyric acid (GHB) administered to humans by means of carbon isotopic ratio analysis: novel perspectives regarding forensic investigation and intelligence issues.
Marclay F., Saudan C., Vienne J., Tafti M., Saugy M., 2011. Analytical and Bioanalytical Chemistry, 400 (4) pp. 1105-1112.
 
Stability and robustness of blood variables in an antidoping context.
Robinson N., Sottas P.E., Pottgiesser T., Schumacher Y.O., Saugy M., 2011. International Journal of Laboratory Hematology, 33 (2) pp. 146-153. Peer-reviewed.
 
Use of forensic investigations in anti-doping.
Jan N., Marclay F., Schmutz N., Smith M., Lacoste A., Castella V., Mangin P., 2011. Forensic Science International, 213 (1-3) pp. 109-113. Peer-reviewed.
 
Sport et dopage
Mangin P., Bollmann M., Saugy M., 2010/02. pp. 512-520 dans Patrick Chariot et Michel Debout (eds.) Traité de médecine légale et de droit de la santé à l'usage des professionnels de la santé et de la justice chap. V, (3), Vuibert.
 
Analysis of hemoglobin-based oxygen carriers by CE-UV/Vis and CE-ESI-TOF/MS.
Staub A., Rudaz S., Saugy M., Veuthey J.L., Schappler J., 2010. Electrophoresis, 31 (7) pp. 1241-1247. Peer-reviewed.
 
Are 10 min of seating enough to guarantee stable haemoglobin and haematocrit readings for the athlete's biological passport?
Ahlgrim C., Pottgiesser T., Robinson N., Sottas P.E., Ruecker G., Schumacher Y.O., 2010. International Journal of Laboratory Hematology, 32 (5) pp. 506-511.
 
Blood transfusion in sports.
Giraud S., Sottas P.E., Robinson N., Saugy M., 2010. pp. 295-304 dans Thieme Detlef, Hemmersbach Peter (eds.) Doping in sports: Biochemical Principles, Effects and Analysis, Springer Berlin Heidelberg.
 
CE-ESI-TOF/MS for human growth hormone analysis.
Staub A., Giraud S., Saugy M., Rudaz S., Veuthey J.L., Schappler J., 2010. Electrophoresis, 31 (2) pp. 388-395.
 
Characterization and classification of matrix effects in biological samples analyses.
Marchi Ivano, Viette Veronique, Badoud Flavia, Fathi Marc, Saugy Martial, Rudaz Serge, Veuthey Jean-Luc, 2010. Journal of Chromatography. A, 1217 (25) pp. 4071-4078.
 
Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatography-tandem mass spectrometry: Potential use of smokeless tobacco products by ice hockey players.
Marclay Francois, Saugy Martial, 2010. Journal of Chromatography. A, 1217 (48) pp. 7528-7538.
 
Diurnal and exercise-related variability of haemoglobin and reticulocytes in athletes.
Schumacher Y.O., Wenning M., Robinson N., Sottas P.E., Ruecker G., Pottgiesser T., 2010. International Journal of Sports Medicine, 31 (4) pp. 225-230. Peer-reviewed.
 
Endogenous steroid profiling in the athlete biological passport.
Sottas P.E., Saugy M., Saudan C., 2010. Endocrinology and Metabolism Clinics of North America, 39 (1) pp. 59-73, viii-ix.
 
Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes.
Robinson Neil, Sottas Pierre-Edouard, Saugy Martial, 2010. Clinical Laboratory, 56 (5-6) pp. 197-206.
 
Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II: Confirmatory analysis.
Badoud F., Grata E., Perrenoud L., Saugy M., Rudaz S., Veuthey J.L., 2010. Journal of Chromatography. A, 1217 (25) pp. 4109-4119.
 
IEF pattern classification-derived criteria for the identification of epoetin-delta in urine.
Lamon S., Boccard J., Sottas P.E., Glatz N., Wuerzner G., Robinson N., Saugy M., 2010. Electrophoresis, 31 (12) pp. 1918-1924.
Importance de l'exposition au tabac chez les jeunes consommateurs de cannabis: un cheval de Troie ?
Bélanger Richard E., Marclay François, Berchtold André, Akré Christina, Saugy Martial, Michaud Pierre-André, Cornuz Jacques, Suris Joan-Carles, 2010. 35 (Raisons de santé ; 172), Lausanne: Institut universitaire de médecine sociale et préventive (IUMSP).
 
Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R., Meyer P., Chtioui H., Saugy M., Kamber M., 2010. Analytical and Bioanalytical Chemistry, 396 (7) pp. 2493-2502. Peer-reviewed.
 
Procedures for monitoring recombinant erythropoietin and analogs in doping.
Lamon S., Robinson N., Saugy M., 2010. Endocrinology and Metabolism Clinics of North America, 39 (1) pp. 141-54, x.
 
Rapid affinity purification of erythropoietin from biological samples using disposable monoliths.
Lönnberg Maria, Dehnes Yvette, Drevin Malin, Garle Mats, Lamon Severine, Leuenberger Nicolas, Quach Trikien, Carlsson Jan, 2010. Journal of Chromatography. A, 1217 (45) pp. 7031-7037.
 
Subject-based steroid profiling and the determination of novel biomarkers for DHT and DHEA misuse in sports.
Van Renterghem P., Van Eenoo P., Sottas P.E., Saugy M., Delbeke F., 2010. Drug Testing and Analysis, 2 (11-12) pp. 582-588.
 
Blood doping with hemoglobin-based oxygen carriers (HBOC): analysis by CE-UV and CE-ESI-TOF/MS
Staub A., Schappler J., Saugy M., Rudaz S., Veuthey J.L., 2009/08., Société Française de Toxicologie Analytique pp. S79 dans Goullé J.P. (eds.) Annales de toxicologie analytique, Poster Présentations: P101, EDP Sciences S.A..
 
Determination of testosterone misuse in sport, an international comparative study
Strahm E., Sottas P.E., Dvorak J., Saugy M., Saudan C., 2009/08., SFTA : Société Française de Toxicologie Analytique pp. S23 dans Jean-Pierre Goullé (eds.) Annales de toxicologie analytique, Oral présentations : 048, EDP Sciences S.A..
 
Development of an IRMS technology for tracing gamma-hydroxybutyric acid (GHB)
Marcley F., Pazos D., Saudan C., Delémont O., Esseiva P., 2009/08., Société Française de Toxicologie Analytique pp. S55 dans Goullé J.P. (eds.) Annales de toxicologie analytique, Poster Presentations: PO40, EDP Sciences S.A..
 
Fast screening and confirmation of doping agents by UHPLC-QTOF-MS/MS
Badoud F., Grata E., Perrenoud L., Saugy M., Rudaz S., Veuthey J.L., 2009/08., Société Française de Toxicologie Analytique pp. S24-S25 dans Goullé Jean-Pierre (eds.) Annales de toxicologie analytique, Oral présentations : 050, EDP Sciences SA.
 
Smoked cannabis and doping control: looking for the wrong target analyte?
Brenneisen R., Meyer P., Chtioui H., Saugy M., Schweizer C., Kamber M., 2009/08., Société Française de Toxicologie Analytique pp. S25 dans Goullé Jean-Pierre (eds.) Annales de toxicologie analytique, Oral présentations : 051, EDP Sciences S.A..
 
A high-throughput test to detect C.E.R.A. doping in blood.
Lamon S., Giraud S., Egli L., Smolander J., Jarsch M., Stubenrauch K.G., Hellwig A., Saugy M., Robinson N., 2009. Journal of Pharmaceutical and Biomedical Analysis, 50 (5) pp. 954-958.
 
Anti-doping testing at the 2008 European football championship.
Vouillamoz M., Thom C., Grisdale R., Saugy M., Giraud S., Robinson N., Gmeiner G., Geisendorfer T., 2009. Drug Testing and Analysis, 1 (11-12) pp. 485-493.
 
Detection in urine of 4-methyl-2-hexaneamine, a doping agent.
Perrenoud L., Saugy M., Saudan C., 2009. Journal of Chromatography. B, 877 (29) pp. 3767-3770.
 
Detection of testosterone administration based on the carbon isotope ratio profiling of endogenous steroids: international reference populations of professional soccer players.
Strahm E., Emery C., Saugy M., Dvorak J., Saudan C., 2009. British journal of sports medicine, 43 (13) pp. 1041-4.
 
Dopage : aspects médico-techniques
Horisberger B., Robinson N., Mangin P., 2009. pp. 543-551 dans Bertrand D., Dumoulin J.-F., La Harpe R., Ummel M. (eds.) Médecin et droit médical, Médecine & Hygiène.
 
Effects of exercise on the isoelectric patterns of erythropoietin.
Lamon S., Martin L., Robinson N., Saugy M., Ceaurriz J., Lasne F., 2009. Clinical Journal of Sport Medicine, 19 (4) pp. 311-315.
 
Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
Badoud F., Grata E., Perrenoud L., Avois L., Saugy M., Rudaz S., Veuthey J.L., 2009. Journal of Chromatography. A, 1216 (20) pp. 4423-4433. Peer-reviewed.
 
Profiling of 19-norandrosterone sulfate and glucuronide in human urine: implications in athlete's drug testing.
Strahm E., Baume N., Mangin P., Saugy M., Ayotte C., Saudan C., 2009. Steroids, 74 (3) pp. 359-364. Peer-reviewed.
 
Steroid profiles of professional soccer players: an international comparative study.
Strahm E., Sottas P.E., Schweizer C., Saugy M., Dvorak J., Saudan C., 2009. British Journal of Sports Medicine, 43 (14) pp. 1126-1130.
 
Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests.
Schulze J.J., Lundmark J., Garle M., Ekström L., Sottas P.E., Rane A., 2009. Steroids, 74 (3) pp. 365-368. Peer-reviewed.
 
The athlete's biological passport and indirect markers of blood doping.
Sottas P.E., Robinson N., Saugy M., 2009. pp. 305-26 dans Thieme Detlef, Hemmersbach Peter (eds.) Doping in sports: Biochemical Principles, Effects and Analysis, Springer Berlin Heidelberg.
 
The fight against doping: back on track with blood.
Saugy M., Robinson N., Saudan C., 2009. Drug Testing and Analysis, 1 (11-12) pp. 474-478.
 
Validation and performance comparison of two carbon isotope ratio methods to control the misuse of androgens in humans.
Saudan C., Emery C., Marclay F., Strahm E., Mangin P., Saugy M., 2009. Journal of Chromatography. B, 877 (23) pp. 2321-2329.
 
Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing".
Saugy M., Robinson N., Lamon S., 2008. Journal of Applied Physiology, 105 (6) pp. 1995-1998. Peer-reviewed.
 
Dopage à l'hormone de croissance dans le sport
Saugy M., Giraud S., Sottas P.E., Robinson N, 2008. Revue francophone des laboratoires, 401 pp. 47-53. Peer-reviewed.
 
Doping: a paradigm shift has taken place in testing.
Sottas P.E., Saudan C., Saugy M., 2008. Nature, 455 (7210) p. 166.
 
From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports.
Sottas P.E., Saudan C., Schweizer C., Baume N., Mangin P., Saugy M., 2008. Forensic Science International, 174 (2-3) pp. 166-172.
 
Isolation and quantification by high-performance liquid chromatography-ion-trap mass spectrometry of androgen sulfoconjugates in human urine.
Strahm E, Kohler I, Rudaz S, Martel S, Carrupt PA, Veuthey JL, Saugy M, Saudan C, 2008. Journal of Chromatography. A, 1196-1197C pp. 153-160.
 
No variation of physical performance and perceived exertion after adrenal gland stimulation by synthetic ACTH (Synacthen) in cyclists.
Baume N., Steel G., Edwards T., Thorstensen E., Miller B.F., 2008. European Journal of Applied Physiology, 104 (4) pp. 589-600. Peer-reviewed.
 
Profiling of 19-norsteroid sulfoconjugates in human urine by liquid chromatography mass spectrometry.
Strahm E, Rudaz S, Veuthey JL, Saugy M, Saudan C, 2008. Analytica Chimica Acta, 613 (2) pp. 228-37.
 
Scientific and forensic standards for homologous blood transfusion anti-doping analyses.
Giraud S, Robinson N, Mangin P, Saugy M, 2008. Forensic Science International, 179 (1) pp. 23-33.
 
Short term impact of Tribulus terrestris intake on doping control analysis of endogenous steroids.
Saudan C., Baume N., Emery C., Strahm E., Saugy M., 2008. Forensic science international, 178 (1) pp. e7-10.
 
Total hemoglobin mass--a new parameter to detect blood doping?
Prommer N., Sottas P.E., Schoch C., Schumacher Y.O., Schmidt W., 2008. Medicine and Science in Sports and Exercise, 40 (12) pp. 2112-2118.
Evolutionary conservation of P-selectin glycoprotein ligand-1 primary structure and function.
Baïsse B., Galisson F., Giraud S., Schapira M., Spertini O., 2007/09/14. BMC evolutionary biology, 7 p. 166. Peer-reviewed.
Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes.
Robinson N., Sottas P.E., Mangin P., Saugy M., 2007/08. Haematologica, 92 (8) pp. 1143-1144. Peer-reviewed.
 
Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio.
Sottas P.E., Baume N., Saudan C., Schweizer C., Kamber M., Saugy M., 2007. Biostatistics, 8 (2) pp. 285-296. Peer-reviewed.
 
Carbon isotopic ratio analysis by gas chromatography/combustion/isotope ratio mass spectrometry for the detection of gamma-hydroxybutyric acid (GHB) administration to humans.
Saudan C., Augsburger M., Mangin P., Saugy M., 2007. Rapid Communications in Mass Spectrometry, 21 (24) pp. 3956-3962. Peer-reviewed.
 
Concentrations of Nandrolone metabolites in urine after the therapeutic administration of an ophthalmic solution
Avois L., Mangin P., Saugy M., 2007. Journal of Pharmaceutical and Biomedical Analysis, 44 (1) pp. 173-179. Peer-reviewed.
 
Detection window of Darbepoetin-alpha following one single subcutaneous injection.
Lamon S., Robinson N., Mangin P., Saugy M., 2007. Clinica Chimica Acta; International Journal of Clinical Chemistry, 379 (1-2) pp. 145-149.
 
Détection biochimique de dopages hormonaux [Biochemical detection of hormone abuse]
Saugy M., 2007. Annales d'Endocrinologie, 68 (4) pp. 304-305. Peer-reviewed.
 
Effective exposure to solar UV in building workers: influence of local and individual factors.
Milon Antoine, Sottas Pierre-Edouard, Bulliard Jean-Luc, Vernez David, 2007. Journal of Exposure Science and Environmental Epidemiology, 17 (1) pp. 58-68. Peer-reviewed.
 
Erytropoietin-blood doping
Robinson N., 2007. pp. 707-711 dans Karch S.B. (eds.) Drug Abuse Handbook chap. 9.3, CRC Press Taylor & Francis Group.
 
Homologous blood transfusion proficiency tests
Giraud S., Georgakopoulos C., de Ceaurriz J., Ayotte C., Segura J., Saugy M., 2007. Recent advances in Doping Analysis, 14 pp. 335-341. Peer-reviewed.
 
Human growh hormone
Saugy M., 2007. pp. 711-714 dans Krach B. (eds.) Drug Abuse Handbook chap. 9.4, CRC Press Taylor & Francis Group.
 
Performance characteristics of two immunoassays for the measurement of urinary luteinizing hormone
Robinson N., Saudan C., Sottas P. E., Mangin P., Saugy M., 2007. Journal of Pharmaceutical and Biomedical Analysis, 43 (1) pp. 270-276. Peer-reviewed.
 
Possible origins of undetectable EPO in urine samples.
Lamon S., Robinson N., Sottas P.E., Henry H., Kamber M., Mangin P., Saugy M., 2007. Clinica Chimica Acta, 385 (1-2) pp. 61-66. Peer-reviewed.
 
SPORTS
M. Bollmann , M. Saugy , 2007. pp. 695-725 dans Stephen Karch (eds.) Drug Abuse Handbook, Second Edition, CRC.
 
Stimulants
Avois-Mateus L., 2007. pp. 703-706 dans Karch S.B. (eds.) Drug Abuse Handbook chap. 9.2, CRC Press Taylor & Francis Group.
 
Successful DNA typing of ultrafiltered urines used to detect EPO doping.
Castella V., Morerod M.L., Robinson N., Saugy M., Mangin P., 2007. Forensic Science International. Genetics, 1 (3-4) pp. 281-282. Peer-reviewed.
 
Testosterone and synthetic anabolic steroids
Saudan C., Baume N., 2007. pp. 700-702 dans Karch S.B. (eds.) Drug Abuse Handbook chap. 9.1, CRC Oress Taylor & Francis Group.
 
Cannabis and sport
Saugy M., Avois L., Saudan C., Robinson N., Giroud C., Mangin P., Dvorak J., 2006. British Journal of Sports Medicine, 40 pp. 13-15. Peer-reviewed.
 
Central nervous system stimulants and sport practice.
Avois L., Robinson N., Saudan C., Baume N., Mangin P., Saugy M., 2006. British journal of sports medicine, 40 Suppl 1 pp. i16-20.
 
Effect of multiple oral doses of androgenic anabolic steroids on endurance performance and serum indices of physical stress in healthy male subjects.
Baume N., Schumacher Y.O., Sottas P.E., Bagutti C., Cauderay M., Mangin P., Saugy M., 2006. European journal of applied physiology, 98 (4) pp. 329-40. Peer-reviewed.
 
Elevated and similar urinary testosterone/epitestosterone ratio in all samples of a competition testing: Suspicion of a manipulation
Robinson N., Castella V., Saudan C., Sottas P. E., Schweizer C., Dimo-Simonin N., Mangin P., Saugy M., 2006. Forensic Science International, 163 (1-2) pp. 148-151. Peer-reviewed.
 
Erythropoietin and blood doping.
Robinson N., Giraud S., Saudan C., Baume N., Avois L., Mangin P., Saugy M., 2006. British journal of sports medicine, 40 Suppl 1 pp. i30-4.
 
Forensic identification of urine samples: a comparison between nuclear and mitochondrial DNA markers.
Castella V., Dimo-Simonin N., Brandt-Casadevall C., Robinson N., Saugy M., Taroni F., Mangin P., 2006. International journal of legal medicine, 120 (2) pp. 67-72. Peer-reviewed.
 
Homologous blood transfusion detection. A new world in anti-doping field: Flow cytometry
Giraud S., Robinson N., Mangin P., Saugy M., 2006. Recent advances in Doping analysis, 13 pp. 265-274. Peer-reviewed.
 
Human growth hormone doping in sport.
Saugy M., Robinson N., Saudan C., Baume N., Avois L., Mangin P., 2006. British journal of sports medicine, 40 Suppl 1 pp. i35-9.
 
Longitudinal profiling of urinary steroids by gas chromatography/combustion/isotope ratio mass spectrometry: Diet change may result in carbon isotopic variations
Saudan C., Kamber M., Barbati G., Robinson N., Desmarchelier A., Mangin P., Saugy M., 2006. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 831 (1-2) pp. 324-327. Peer-reviewed.
 
Research of stimulants and anabolic steroids in dietary supplements.
Baume N., Mahler N., Kamber M., Mangin P., Saugy M., 2006. Scandinavian journal of medicine & science in sports, 16 (1) pp. 41-8. Peer-reviewed.
 
Short-term stability of testosterone and epitestosterone conjugates in urine samples: quantification by liquid chromatography-linear ion trap mass spectrometry.
Saudan C., Entenza J.M., Baume N., Mangin P., Saugy M., 2006. Journal of Chromatography. B, Analytical Technologies In the Biomedical and Life Sciences, 844 (1) pp. 168-174.
 
Statistical classification of abnormal blood profiles in athletes.
Sottas P.E., Robinson N., Giraud S., Taroni F., Kamber M., Mangin P., Saugy M., 2006. The International Journal of Biostatistics, 2 (1) pp. 11-21.
 
Testosterone and doping control.
Saudan C., Baume N., Robinson N., Avois L., Mangin P., Saugy M., 2006. British journal of sports medicine, 40 Suppl 1 pp. i21-4.
 
Use of isotope ratio mass spectrometry to detect doping with oral testosterone undecanoate: inter-individual variability of 13C/12C ratio.
Baume N., Saudan C., Desmarchelier A., Strahm E., Sottas P.E., Bagutti C., Cauderay M., Schumacher Y.O., Mangin P., Saugy M., 2006. Steroids, 71 (5) pp. 364-70. Peer-reviewed.
 
A validated liquid chromatography-mass spectrometry method for the determination of leukotrienes B4 and B5 produced by stimulated human polymorphonuclear leukocytes
Panchaud A., Avois L., Roulet M., Pilet M., Hug C., Saugy M., Decosterd L. A., 2005/06. Analytical Biochemistry, 341 (1) pp. 58-68.
 
Blood analysis.
Brandt-Casadevall C, Dimo-Simonin N, 2005. pp. 373-379 dans Encyclopedia of analytical science. Second edition, Elsevier.
 
Characterisation of three Amerindian populations from Hidalgo State (Mexico) by 15 STR-PCR polymorphisms
Barrot C., Sanchez C., Ortega M., Gonzalez-Martin A., Brand-Casadevall C., Gorostiza A., Huguet E., Corbella J., Gene M., 2005. International Journal of Legal Medicine, 119 (2) pp. 111-115.
 
Detection of exogenous GHB in blood by gas chromatography-combustion-isotope ratio mass spectrometry: implications in postmortem toxicology.
Saudan C., Augsburger M., Kintz P., Saugy M., Mangin P., 2005. Journal of analytical toxicology, 29 (8) pp. 777-781. Peer-reviewed.
 
Effects of high-intensity exercises on 13C-nandrolone excretion in trained athletes.
Baume N., Avois L., Sottas P.E., Dvorak J., Cauderay M., Mangin P., Saugy M., 2005. Clinical Journal of Sport Medicine, 15 (3) pp. 158-166. Peer-reviewed.
 
Haematological analysis conducted at the departure of the Tour de France 2001.
Robinson N., Schattenberg L., Zorzoli M., Mangin P., Saugy M., 2005. International Journal of Sports Medicine, 26 (3) pp. 200-207.
 
Haematological testing to fight wood doping response - Letter to the editors: Haematological testing and antidoping policies
Robinson N., Mangin P., Saugy M., 2005. International Journal of Sports Medicine, 26 (6) pp. 510-511. Peer-reviewed.
 
Regulation of PSGL-1 interactions with L-selectin, P-selectin, and E-selectin: role of human fucosyltransferase-IV and -VII.
Martinez M., Joffraud M., Giraud S., Baïsse B., Bernimoulin M.P., Schapira M., Spertini O., 2005. Journal of Biological Chemistry, 280 (7) pp. 5378-5390. Peer-reviewed.
 
Urinary marker of oral pregnenolone administration
Saudan C., Desmarchelier A., Sottas P. E., Mangin P., Saugy M., 2005. Steroids, 70 (3) pp. 179-183. Peer-reviewed.
 
Use of ion trap gas chromatography-multiple mass spectrometry for the detection and confirmation of 3 ' hydroxystanozolol at trace levels in urine for doping control
Mateus-Avois L., Mangin P., Saugy M., 2005. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 816 (1-2) pp. 193-201. Peer-reviewed.
 
[13C]Nandrolone excretion in trained athletes: interindividual variability in metabolism.
Baume N., Avois L., Schweizer C., Cardis C., Dvorak J., Cauderay M., Mangin P., Saugy M., 2004. Clinical Chemistry, 50 (2) pp. 355-364. Peer-reviewed.
 
Abnormally high serum ferritin levels among professional road cyclists
Zotter H., Robinson N., Zorzoli M., Schattenberg L., Saugy M., Mangin P., 2004. British Journal of Sports Medicine, 38 (6) pp. 704-708. Peer-reviewed.
 
C13-labelled nandrolone excretion in trained athletes: Effect of exercise
Baume N., Avois L., Cauderay M., Dvorak J., Mangin P., Saugy M., 2004. Medicine and Science in Sports and Exercise, 36 (5) pp. S170. Peer-reviewed.
 
Death following acute poisoning by moclobemide
Giroud C., Horisberger B., Eap C., Augsburger M., Ménétrey A., Baumann P., Mangin P., 2004. Forensic science international, 140 (1) pp. 101-107. Peer-reviewed.
 
Former les médecins de demain
Mangin P., 2004. Médecine et Hygiène, 62 (N° spécial) pp. s2.
 
Hna hnu Amerindian population from La Sierra Otomi-Tepehua (Mexico) characterised by 14 STR-PCR polymorphisms.
Barrot-Feixat C, Gonzalez-Martin A, Ortega M, Sanchez C, Gorotiza A, Hugeut E, Brandt-Casadevall C, Corbella J, Gené M, 2004. International Congress Series, 1261 pp. 182-184.
Transparent     Swiss University
Unicentre  -  CH-1015 Lausanne  -  Suisse  -  Tél. +41 21 692 11 11  -  Fax +41 21 692 20 15